CD7 CAR T-Cell Therapy and Allogeneic HSCT. Reply. | N Engl J Med;391(1): 93, 2024 Jul 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

CD7 CAR T-Cell Therapy and Allogeneic HSCT. Reply.

Hu, Yongxian; Wang, Dongrui; Huang, He.

Affiliation

Hu Y; First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China huanghe@zju.edu.cn.
Wang D; First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China huanghe@zju.edu.cn.
Huang H; First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China huanghe@zju.edu.cn.

N Engl J Med ; 391(1): 93, 2024 Jul 04.

Article in En | MEDLINE | ID: mdl-38959487

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Hematopoietic Stem Cell Transplantation Limits: Humans Language: En Journal: N Engl J Med Year: 2024 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Hematopoietic Stem Cell Transplantation Limits: Humans Language: En Journal: N Engl J Med Year: 2024 Document type: Article Affiliation country: Country of publication: